Neurobiological Technologies, Inc. (NTII)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Nov 14, 2025
NTII Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | 2000 - 2004 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '09 Dec 17, 2009 | Jun '09 Jun 30, 2009 | Jun '08 Jun 30, 2008 | Jun '07 Jun 30, 2007 | Jun '06 Jun 30, 2006 | Jun '05 Jun 30, 2005 | 2000 - 2004 |
| 25.32 | 26.35 | 14.76 | 17.67 | 12.34 | 3.1 | Upgrade | |
Revenue Growth (YoY) | 77.65% | 78.52% | -16.48% | 43.23% | 298.10% | 11.23% | Upgrade |
Gross Profit | 25.32 | 26.35 | 14.76 | 17.67 | 12.34 | 3.1 | Upgrade |
Selling, General & Admin | 4.09 | 5.08 | 6.88 | 6.54 | 5.97 | 4.93 | Upgrade |
Research & Development | 1.74 | 17.58 | 24.58 | 26.74 | 22.81 | 10.75 | Upgrade |
Operating Expenses | 5.83 | 22.67 | 31.46 | 33.27 | 28.78 | 15.68 | Upgrade |
Operating Income | 19.49 | 3.68 | -16.7 | -15.6 | -16.44 | -12.58 | Upgrade |
Interest Expense | - | - | -2.48 | - | - | - | Upgrade |
Interest & Investment Income | 0.28 | 0.75 | 1.25 | 0.49 | 0.4 | 0.25 | Upgrade |
Other Non Operating Income (Expenses) | 0 | -0.26 | 3.38 | 0.98 | - | - | Upgrade |
EBT Excluding Unusual Items | 19.77 | 4.18 | -14.54 | -14.13 | -16.04 | -12.33 | Upgrade |
Gain (Loss) on Sale of Investments | -0.83 | -0.86 | -1.78 | - | - | - | Upgrade |
Asset Writedown | -0.19 | -0.19 | - | - | - | - | Upgrade |
Pretax Income | 18.72 | 3.12 | -16.32 | -14.13 | -27.54 | -24.98 | Upgrade |
Income Tax Expense | 0.05 | - | - | - | 0.3 | - | Upgrade |
Net Income | 18.67 | 3.12 | -16.32 | -14.13 | -27.84 | -24.98 | Upgrade |
Net Income to Common | 18.67 | 3.12 | -16.32 | -14.13 | -27.84 | -24.98 | Upgrade |
Shares Outstanding (Basic) | 27 | 27 | 19 | 4 | 4 | 4 | Upgrade |
Shares Outstanding (Diluted) | 27 | 27 | 19 | 4 | 4 | 4 | Upgrade |
Shares Change (YoY) | 0.34% | 38.63% | 348.06% | 6.59% | 7.39% | 28.30% | Upgrade |
EPS (Basic) | 0.69 | 0.12 | -0.84 | -3.26 | -6.84 | -6.59 | Upgrade |
EPS (Diluted) | 0.69 | 0.12 | -0.84 | -3.26 | -6.84 | -6.59 | Upgrade |
Free Cash Flow | -3.69 | -16.43 | -20.71 | -13.2 | 8.63 | -10.05 | Upgrade |
Free Cash Flow Per Share | -0.14 | -0.61 | -1.06 | -3.04 | 2.12 | -2.65 | Upgrade |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade |
Operating Margin | 76.97% | 13.98% | -113.12% | -88.28% | -133.21% | -405.76% | Upgrade |
Profit Margin | 73.72% | 11.85% | -110.58% | -79.94% | -225.62% | -805.86% | Upgrade |
Free Cash Flow Margin | -14.58% | -62.36% | -140.30% | -74.67% | 69.92% | -324.24% | Upgrade |
EBITDA | 19.54 | 3.82 | -16.49 | -15.37 | -16.24 | -12.5 | Upgrade |
EBITDA Margin | 77.17% | 14.48% | -111.73% | -86.97% | -131.64% | - | Upgrade |
D&A For EBITDA | 0.05 | 0.13 | 0.21 | 0.23 | 0.19 | 0.07 | Upgrade |
EBIT | 19.49 | 3.68 | -16.7 | -15.6 | -16.44 | -12.58 | Upgrade |
EBIT Margin | 76.97% | 13.98% | -113.12% | -88.28% | -133.21% | - | Upgrade |
Effective Tax Rate | 0.28% | - | - | - | - | - | Upgrade |
Revenue as Reported | 25.32 | 26.35 | 14.76 | 17.67 | 12.34 | 3.1 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.